Skip to main content

Upcoming Webinar

Laptop computer.

Safely manage patients through mental health challenges including drug discontinuation and shortages

Date: 20th November 2025
Starts: 14:00 GMT (14:00 UTC, 09:00 EST)
Duration: 40 minutes

Join us for an expert-led webinar with Psychotropic Drug Directory Editor, Nicola Greenhalgh as we discuss a recent update to the trusted guidance triggered by the discontinuation from the UK market of Pabrinex and a shortage of the IV pabrinex, and more.

Register

By the end of this webinar, you will be able to:

  • Understand the evidence-based guidance and dose recommendations when treating or preventing Alcohol withdrawal syndrome (AWS), in light of recent drug discontinuations/shortages.
  • See how Psychotropic Drug Directory has evolved over nearly 2 years since it was launched on MedicinesComplete and be aware of some exciting new guidance on weight gain and GLP-1 agonists.
  • With a real-life case study see how Psychotropic Drug Directory can support day to day queries.

Why this matters:

Management of drug shortages and discontinuations is a common challenge, especially in mental health care. Trusted, evidence-based guidance is crucial when safely managing patients through the change.

Hosted by:

Matt Orzlowski
International Account Manager.

Speakers:

Nicola Greenhalgh
Editor of Psychotropic Drug Directory, Nicola has worked in mental health for over 13 years with experience managing a specialist mental health medicines information service and is currently the deputy chief pharmacist at Essex Partnership University NHS Foundation Trust and the Vice-president of the College of Mental Health Pharmacy.
Louisa Marchant-Rutherford
A member of the Pharmaceutical Press expert editorial team, Louisa has over 16 years of experience in pharmacy and is currently Lead Pharmacist and Independent Prescriber (specialist older adults and Dementia) at Sussex Partnership NHS Foundation Trust

Register for this webinar now

Simply fill in the form below to access this webinar. All fields are required.

We collect and process data in accordance with our Privacy Policy.

Disclaimer

MedicinesComplete is aimed at health professionals and assumes a level of professional training to interpret the information on this site. Information on the selection and clinical use of medicines is designed for prescribers, pharmacists and other health professionals and is not suitable for patients or the general public. All information should be interpreted in light of professional knowledge and supplemented as necessary with specialist publications, and all users are responsible for ensuring appropriate use or reliance on such information. Although RPS make reasonable efforts to update the information on MedicinesComplete, RPS make no representations, warranties or guarantees, whether express or implied, that the content is accurate, complete, or up to date. So far as permitted by law, RPS will not accept liability for damages, in any form, arising from or in relation to MedicinesComplete, or for a temporary inability to access this site. For more information please see our Website Terms and Conditions. © The Royal Pharmaceutical Society, 2025. Copying of MedicinesComplete content without permission is not permitted.

Access the essential knowledge you need today

Medicines Complete.

Instant online access to our essential knowledge 24/7

Book a demo

Pharmaceutical Journal.

The Royal Pharmaceutical Society’s official journal

Subscribe

Pharmacy Knowledge.

Trusted knowledge and revision for tomorrow's pharmacists

ONtrack

Research Journals.

High impact research in pharmaceutical sciences

Read